Tamsulosin for Urinary Retention After Pelvic Surgery

Recruiting in Palo Alto (17 mi)

Age: Any Age

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase < 1

Waitlist Available

Sponsor: The Cleveland Clinic

Trial Summary

What is the purpose of this trial?Our hypothesis is that patients receiving preoperative Tamsulosin will have decrease rates of postoperative urinary retention (POUR) after surgery in females for pelvic floor disorders.

Eligibility Criteria

This trial is for female patients undergoing surgery for pelvic floor disorders, including various vaginal, laparoscopic, and robotic surgeries. Candidates must not have preoperative urinary retention, cancer, neurological diseases or spinal cord injuries. They also can't be allergic to Tamsulosin or need long-term post-surgery bladder drainage.

Inclusion Criteria

I have had surgery for pelvic organ prolapse or incontinence.

I am having surgery for prolapse, possibly with a sling procedure.

Exclusion Criteria

I needed long-term bladder support after surgery due to complications.

I have been diagnosed with urinary retention before surgery.

I have been diagnosed with cancer.

+4 more

Participant Groups

The study tests if taking Tamsulosin before surgery reduces the chances of having difficulty urinating after pelvic floor disorder surgery. Participants will either receive Tamsulosin or a placebo tablet without knowing which one they are getting.

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Preoperative TamsulosinExperimental Treatment1 Intervention

The study group will receive one oral dose .4mg of Tamsulosin prior to surgery.

Group II: Preoperative PlaceboPlacebo Group1 Intervention

The control group will receive one oral dose of placebo pill prior to surgery.